Inflammatory myofibroblastic tumor (inflammatory pseudotumor): DNA flow cytometric analysis of nine pediatric cases

Roberto Biselli, Cristiano Ferlini, Andrea Fattorossi, Renata Boldrini, Cesare Bosman

Research output: Contribution to journalArticle

131 Citations (Scopus)

Abstract

BACKGROUND. Inflammatory myofibroblastic tumor or inflammatory pseudotumor is an uncommon lesion reported in various organs and believed to be a non- neoplastic reactive inflammatory condition. The concept of benign lesion has been recently challenged from both clinical demonstration of recurrence and cytogenetic evidence of acquired clonal chromosomal abnormality. Because DNA aneuploidy can be a useful marker for neoplasia, we analyzed nuclear DNA content of these lesions using flow cytometry. METHODS. In this study, inflammatory myofibroblastic tumors from nine children were examined retrospectively by evaluating clinicopathologic features and ploidy. DNA ploidy status was analyzed by flow cytometry in nuclei isolated from paraffin-embedded tumor tissues. RESULTS. Three of the nine patients had local recurrence or distant metastases. Flow cytometric DNA analysis revealed five of the nine cases were diploid and four hyperdiploid (DNA indices 1.14, 1.16, 1.19, and 1.33). All lesions had a low S-phase fraction. Samples from the three subjects with clinical recurrence were all hyperdiploid. CONCLUSIONS. The present data indicate that flow cytometry identifies aneuploidy (hyperdiploidy) in approximately half of the cases of inflammatory myofibroblastic tumors. This feature appears to reflect a more aggressive biologic behavior. In addition to the reported cytogenetic abnormalities, our data suggest that inflammatory myofibroblastic tumor, generally considered a benign reactive inflammatory process, may evolve as a distinct, potentially malignant, lesion. Therefore, flow cytometric DNA analysis is a suitable tool to provide the clinician with both diagnostic and prognostic information and to individuate the most feasible therapeutic approach.

Original languageEnglish
Pages (from-to)778-784
Number of pages7
JournalCancer
Volume77
Issue number4
DOIs
Publication statusPublished - Feb 15 1996

Fingerprint

Plasma Cell Granuloma
Pediatrics
Polyploidy
DNA
Neoplasms
Flow Cytometry
Ploidies
Aneuploidy
Recurrence
Chromosome Aberrations
Diploidy
S Phase
Cytogenetics
Paraffin
Neoplasm Metastasis

Keywords

  • aneuploidy
  • DNA content
  • flow cytometry
  • inflammatory myofibroblastic tumor
  • inflammatory pseudotumor
  • pediatric neoplasia

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Inflammatory myofibroblastic tumor (inflammatory pseudotumor) : DNA flow cytometric analysis of nine pediatric cases. / Biselli, Roberto; Ferlini, Cristiano; Fattorossi, Andrea; Boldrini, Renata; Bosman, Cesare.

In: Cancer, Vol. 77, No. 4, 15.02.1996, p. 778-784.

Research output: Contribution to journalArticle

Biselli, Roberto ; Ferlini, Cristiano ; Fattorossi, Andrea ; Boldrini, Renata ; Bosman, Cesare. / Inflammatory myofibroblastic tumor (inflammatory pseudotumor) : DNA flow cytometric analysis of nine pediatric cases. In: Cancer. 1996 ; Vol. 77, No. 4. pp. 778-784.
@article{cbee57ccb7cc4cb4833827f132b56c3d,
title = "Inflammatory myofibroblastic tumor (inflammatory pseudotumor): DNA flow cytometric analysis of nine pediatric cases",
abstract = "BACKGROUND. Inflammatory myofibroblastic tumor or inflammatory pseudotumor is an uncommon lesion reported in various organs and believed to be a non- neoplastic reactive inflammatory condition. The concept of benign lesion has been recently challenged from both clinical demonstration of recurrence and cytogenetic evidence of acquired clonal chromosomal abnormality. Because DNA aneuploidy can be a useful marker for neoplasia, we analyzed nuclear DNA content of these lesions using flow cytometry. METHODS. In this study, inflammatory myofibroblastic tumors from nine children were examined retrospectively by evaluating clinicopathologic features and ploidy. DNA ploidy status was analyzed by flow cytometry in nuclei isolated from paraffin-embedded tumor tissues. RESULTS. Three of the nine patients had local recurrence or distant metastases. Flow cytometric DNA analysis revealed five of the nine cases were diploid and four hyperdiploid (DNA indices 1.14, 1.16, 1.19, and 1.33). All lesions had a low S-phase fraction. Samples from the three subjects with clinical recurrence were all hyperdiploid. CONCLUSIONS. The present data indicate that flow cytometry identifies aneuploidy (hyperdiploidy) in approximately half of the cases of inflammatory myofibroblastic tumors. This feature appears to reflect a more aggressive biologic behavior. In addition to the reported cytogenetic abnormalities, our data suggest that inflammatory myofibroblastic tumor, generally considered a benign reactive inflammatory process, may evolve as a distinct, potentially malignant, lesion. Therefore, flow cytometric DNA analysis is a suitable tool to provide the clinician with both diagnostic and prognostic information and to individuate the most feasible therapeutic approach.",
keywords = "aneuploidy, DNA content, flow cytometry, inflammatory myofibroblastic tumor, inflammatory pseudotumor, pediatric neoplasia",
author = "Roberto Biselli and Cristiano Ferlini and Andrea Fattorossi and Renata Boldrini and Cesare Bosman",
year = "1996",
month = "2",
day = "15",
doi = "10.1002/(SICI)1097-0142(19960215)77:4<778::AID-CNCR25>3.0.CO;2-X",
language = "English",
volume = "77",
pages = "778--784",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Inflammatory myofibroblastic tumor (inflammatory pseudotumor)

T2 - DNA flow cytometric analysis of nine pediatric cases

AU - Biselli, Roberto

AU - Ferlini, Cristiano

AU - Fattorossi, Andrea

AU - Boldrini, Renata

AU - Bosman, Cesare

PY - 1996/2/15

Y1 - 1996/2/15

N2 - BACKGROUND. Inflammatory myofibroblastic tumor or inflammatory pseudotumor is an uncommon lesion reported in various organs and believed to be a non- neoplastic reactive inflammatory condition. The concept of benign lesion has been recently challenged from both clinical demonstration of recurrence and cytogenetic evidence of acquired clonal chromosomal abnormality. Because DNA aneuploidy can be a useful marker for neoplasia, we analyzed nuclear DNA content of these lesions using flow cytometry. METHODS. In this study, inflammatory myofibroblastic tumors from nine children were examined retrospectively by evaluating clinicopathologic features and ploidy. DNA ploidy status was analyzed by flow cytometry in nuclei isolated from paraffin-embedded tumor tissues. RESULTS. Three of the nine patients had local recurrence or distant metastases. Flow cytometric DNA analysis revealed five of the nine cases were diploid and four hyperdiploid (DNA indices 1.14, 1.16, 1.19, and 1.33). All lesions had a low S-phase fraction. Samples from the three subjects with clinical recurrence were all hyperdiploid. CONCLUSIONS. The present data indicate that flow cytometry identifies aneuploidy (hyperdiploidy) in approximately half of the cases of inflammatory myofibroblastic tumors. This feature appears to reflect a more aggressive biologic behavior. In addition to the reported cytogenetic abnormalities, our data suggest that inflammatory myofibroblastic tumor, generally considered a benign reactive inflammatory process, may evolve as a distinct, potentially malignant, lesion. Therefore, flow cytometric DNA analysis is a suitable tool to provide the clinician with both diagnostic and prognostic information and to individuate the most feasible therapeutic approach.

AB - BACKGROUND. Inflammatory myofibroblastic tumor or inflammatory pseudotumor is an uncommon lesion reported in various organs and believed to be a non- neoplastic reactive inflammatory condition. The concept of benign lesion has been recently challenged from both clinical demonstration of recurrence and cytogenetic evidence of acquired clonal chromosomal abnormality. Because DNA aneuploidy can be a useful marker for neoplasia, we analyzed nuclear DNA content of these lesions using flow cytometry. METHODS. In this study, inflammatory myofibroblastic tumors from nine children were examined retrospectively by evaluating clinicopathologic features and ploidy. DNA ploidy status was analyzed by flow cytometry in nuclei isolated from paraffin-embedded tumor tissues. RESULTS. Three of the nine patients had local recurrence or distant metastases. Flow cytometric DNA analysis revealed five of the nine cases were diploid and four hyperdiploid (DNA indices 1.14, 1.16, 1.19, and 1.33). All lesions had a low S-phase fraction. Samples from the three subjects with clinical recurrence were all hyperdiploid. CONCLUSIONS. The present data indicate that flow cytometry identifies aneuploidy (hyperdiploidy) in approximately half of the cases of inflammatory myofibroblastic tumors. This feature appears to reflect a more aggressive biologic behavior. In addition to the reported cytogenetic abnormalities, our data suggest that inflammatory myofibroblastic tumor, generally considered a benign reactive inflammatory process, may evolve as a distinct, potentially malignant, lesion. Therefore, flow cytometric DNA analysis is a suitable tool to provide the clinician with both diagnostic and prognostic information and to individuate the most feasible therapeutic approach.

KW - aneuploidy

KW - DNA content

KW - flow cytometry

KW - inflammatory myofibroblastic tumor

KW - inflammatory pseudotumor

KW - pediatric neoplasia

UR - http://www.scopus.com/inward/record.url?scp=0030020615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030020615&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0142(19960215)77:4<778::AID-CNCR25>3.0.CO;2-X

DO - 10.1002/(SICI)1097-0142(19960215)77:4<778::AID-CNCR25>3.0.CO;2-X

M3 - Article

C2 - 8616772

AN - SCOPUS:0030020615

VL - 77

SP - 778

EP - 784

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 4

ER -